Cardiac, vascular, circulation, and blood-flow pathways under study.
10 results
Other research compound
Researchers are studying this compound in relation to vascular tone and circulation pathways.
Level 5 · Regulatory Review or Established Clinical Use
Claim: Vascular function and circulation
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Approved prostaglandin therapy in urology and neonatal care.
View evidence map →Individual peptide
ARA-290 is examined in studies of cardiac and microvascular pathways.
Level 4 · Controlled Human Studies
Claim: Vascular function and circulation
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Randomized controlled trials in neuropathic pain and sarcoidosis.
View evidence map →Individual peptide
Research interest in Cardiogen centres on endothelial function and blood-flow signaling.
Level 2 · Animal Research
Claim: Vascular function and circulation
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Animal and cell bioregulator studies from a limited research group.
View evidence map →Other research compound
This compound is examined in studies of cardiac and microvascular pathways.
Level 5 · Regulatory Review or Established Clinical Use
Claim: Vascular function and circulation
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Approved erythropoiesis-stimulating agent in clinical use.
View evidence map →Individual peptide
Research interest in Humanin centres on endothelial function and blood-flow signaling.
Level 2 · Animal Research
Claim: Vascular function and circulation
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Animal and cell studies of mitochondrial and neuroprotective signaling.
View evidence map →Individual peptide
MOTS-c is examined in studies of cardiac and microvascular pathways.
Level 2 · Animal Research
Claim: Vascular function and circulation
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Animal and cell studies of mitochondrial signaling; human data minimal.
View evidence map →Individual peptide
Research interest in SS-31 centres on endothelial function and blood-flow signaling.
Level 4 · Controlled Human Studies
Claim: Vascular function and circulation
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Randomized elamipretide trials in mitochondrial and cardiac disease.
View evidence map →Blend · 2 components
Research interest in this blend centres on endothelial function and blood-flow signaling.
Published evidence — exact blend
Not yet reviewed
Components (reviewed separately)
Individual peptide
Vesugen is examined in studies of cardiac and microvascular pathways.
Level 1 · Laboratory Research
Claim: Vascular function and circulation
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Laboratory bioregulator work only.
View evidence map →Individual peptide
Research interest in VIP centres on endothelial function and blood-flow signaling.
Level 4 · Controlled Human Studies
Claim: Vascular function and circulation
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Controlled aviptadil trials in respiratory and pulmonary conditions.
View evidence map →Every result card shows the same five-segment bar. Each level below matches the color of that segment.
Level 1: Laboratory Research
Observed in cells, tissue, or computational models only.
Level 2: Animal Research
Studied in animal models; results often do not transfer to people.
Level 3: Early Human Research
Human research
Small, early-stage, or uncontrolled studies in humans.
Level 4: Controlled Human Studies
Human research
Randomized or otherwise controlled human trials exist.
Level 5: Regulatory Review or Established Clinical Use
Human research
Reviewed by a regulator or established in clinical practice for a specific use.
Evidence is rated by claim—not popularity. More studies do not always mean stronger evidence.
A higher level describes research maturity. It is not a recommendation or endorsement.
Educational information only. Not medical advice.
0 peptides selected
Select up to 6 peptides to compare.